Health Care/Hospital

Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)

MELBOURNE, Australia, Jan. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company's theranostic programs at the upcoming American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2024) to be he...

2024-01-22 19:00 1304

Asia Research News provides a source-finding platform for journalists

A one-stop resource for expertise and science is now available. Get tip sheets for research stories fromAsia. CAMBRIDGE, England and PENANG, Malaysia, Jan. 22, 2024 /PRNewswire/ -- Asia Research News, the unrivalled leader of scientific news and experts forAsia, is set to sail into its 20th yea...

2024-01-22 17:00 1562

KL Wellness City Drives Healthcare Tourism with IoT Integration

KUALA LUMPUR, Malaysia, Jan. 22, 2024 /PRNewswire/ -- Since its grand launch in June 2023, KL Wellness City (KLWC) has been a trailblazer, reshaping integrated healthcare and wellness. This visionary city, housing the flagship KL International Hospital (KLIH) and The Nobel Healthcare Park, is set...

2024-01-22 12:50 1755

Guangdong on the Road | Angels that give sight in Fiji

GUANGZHOU, China, Jan. 22, 2024 /PRNewswire/ -- Through the "Guangdong on the Road" series, GDToday joins hands with global reporters and sheds light on Guangdong's partnership under the Belt and Road Initiative.   2023 marks the 60th anniversary of China dispatching its first Chinese medical te...

2024-01-22 10:35 1607

xTool's First-Ever Brand Safety Campaign Kicks Off with a Notable Trade-In Program

IRWINDALE, Calif., Jan. 22, 2024 /PRNewswire/ -- xTool , an industry-leading laser cutter and engraver brand, is excited to announce the launch of its first-ever safety-themed brand campaign

2024-01-22 10:00 1285

Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million

SHANGHAI, Jan. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Company expects to record a total reven...

2024-01-22 07:50 3071

/C O R R E C T I O N -- Life Fitness/

In the news release, EGYM and Life Fitness Expands Existing Global Partnership, issued18-Jan-2024 by Life Fitness over PR Newswire, we are advised by the company that the second paragraph, second sentence, should read "..is expected to be launched in the first half of 2024" rather than "..is expe...

2024-01-19 23:42 4160

Top Employer 2024 certification reflects Boehringer Ingelheim Vietnam's impactful people development

HO CHI MINH CITY, Vietnam, Jan. 19, 2024 /PRNewswire/ -- For the fifth consecutive year, Boehringer Ingelheim Vietnam, a biopharmaceutical company focused on research, has received recognition for its exceptionalworkplace. Globally, Boehringer Ingelheim has been recognized as a "Global Top Employ...

2024-01-19 19:28 1549

Call for Application for 2024 Tsinghua Amgen Scholars Program

BEIJING, Jan. 19, 2024 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science. Thr...

2024-01-19 15:32 2493

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Indonesia

Note: This press release, with MLR code: MPR-ID-100139, supersedes the version issued on 18/01/2024, 11:00. *  Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inIndonesia *  High scores in development and steering (strategy and leadershi...

2024-01-19 13:15 1394

Co-creating a New Future: Infinitus Global Annual Conference 2024 Convenes in Guangdong

GUANGZHOU, China, Jan. 18, 2024 /PRNewswire/ -- Infinitus kicked off 2024 with the 'Co-creating a New Future' annual conference held in Foshan,Guangdong on January 13, 2024. Family members of the Lee Kum Kee Group and Infinitus’ Central Management ...

2024-01-19 11:42 1711

Airai Global Corporation Officially Team Up with Airai State Government Palau Joint Developed Integrated Luxuries Tourism & Modern Wellness Transformation Program

Double Collaboration Agreement Signing Marks a Milestone at Sheraton Petaling Jaya Hotel KUALA LUMPUR, Malaysia, Jan. 19, 2024 /PRNewswire/ -- The Airai State Government welcomes Airai Global Corporation in a historic collaboration to revolutionize eco-tourism and healthcare inPalau. This transf...

2024-01-19 10:00 1738

Leapstack has raised nearly 200 million RMB in Series C+ Funding, building a diversified technological value chain for health insurance

SHANGHAI, Jan. 18, 2024 /PRNewswire/ -- Leapstack, a prominent insurtech company, recently secured an impressive200 million RMB yuan in Series C+ Funding, led by Qiming Venture Partners. The funding round also saw active participation from Soochow Yihe Capital, and existing shareholder Legend Ca...

2024-01-18 22:34 1777

Leapstack has raised nearly 200 million RMB in Series C+ Funding, building a diversified technological value chain for health insurance

SHANGHAI, Jan. 18, 2024 /PRNewswire/ -- Leapstack, a prominent insurtech company, recently secured an impressive200 million RMB yuan in Series C+ Funding, led by Qiming Venture Partners. The funding round also saw active participation from Soochow Yihe Capital, and existing shareholder Legend Ca...

2024-01-18 22:18 1796

PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

IRVINE, Calif., Jan. 18, 2024 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the cohort 1 first patient treated in its Phase 1 relapsed or refractory B-cell acute lymphoblastic leukemia (...

2024-01-18 16:00 2185

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Malaysia

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inMalaysia * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development KUALA ...

2024-01-18 12:00 1289

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Indonesia

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inIndonesia * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development JAK...

2024-01-18 12:00 1323

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Asia Pacific

* Boehringer Ingelheim is recognized as one of 17 Top Employers worldwide and for the fifth consecutive year inAsia Pacific * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development...

2024-01-18 12:00 1478

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Thailand

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inThailand * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development BANGKO...

2024-01-18 12:00 1273

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024

* Octapharma will present new clinical and scientific findings for wilate® and Nuwiq® * New findings in von Willebrand disease (VWD) and haemophilia A, will be presented by leading experts in a Satellite Symposium, as well as an oral and six poster presentations * Presentations will include...

2024-01-18 02:20 1591
1 ... 22232425262728 ... 553